The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638)
Public ClinicalTrials.gov record NCT00894530. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT00894530
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Merck Sharp & Dohme LLC
- Industry
- Enrollment
- 314 participants
Conditions and interventions
Conditions
Interventions
- Azithromycin ophthalmic solution, 1% Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2009
- Primary completion
- Nov 30, 2009
- Completion
- Nov 30, 2009
- Last update posted
- Nov 20, 2013
2009
United States locations
- U.S. sites
- 26
- U.S. states
- 16
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Schwartz Laser Eye Center | Scottsdale | Arizona | 85260 | — |
| McDonald Eye Associates | Fayetteville | Arkansas | 72703 | — |
| Sall Research Medical Center, Inc. | Artesia | California | 90701 | — |
| Sall Research Medical Center | Artesia | California | 90701 | — |
| United Medical Research Company | Inglewood | California | 90301 | — |
| North Valley Eye Medical Group | Mission Hills | California | 91345 | — |
| Coastal Vision Medical Group | Newport Beach | California | 92660 | — |
| West Coast Eye Care | San Diego | California | 92115-1754 | — |
| Hernando Eye Institute | Brooksville | Florida | 34613 | — |
| Center for Excellence in Eye Care | Miami | Florida | 33176 | — |
| Wohl Eye Center | Bloomingdale | Illinois | 60108 | — |
| Thomas John Vision Institute | Tinley Park | Illinois | 60477 | — |
| Grene Vision Group | Wichita | Kansas | 67208 | — |
| Taustine Eye Center | Louisville | Kentucky | 40217 | — |
| Eastern Maine Medical Center | Bangor | Maine | 04401 | — |
| Ophthalmology Associates | St Louis | Missouri | 63131 | — |
| Comprehensive Eye Care Ltd | Washington | Missouri | 63090 | — |
| David M. Ringel, DO, PA | Sewell | New Jersey | 08080 | — |
| Brar-Parekh Eye Associates | Woodland Park | New Jersey | 07424 | — |
| Ophthalmic Consultants of Long Island | Lynbrook | New York | 11563 | — |
| Park Ophthalmology | Durham | North Carolina | 27713 | — |
| Ohio State University - College of Optometry | Columbus | Ohio | 43210 | — |
| Columbus Ophthalmology Associates | Columbus | Ohio | 43213 | — |
| Philadelphia Eye Associates | Philadelphia | Pennsylvania | 19148 | — |
| Total Eye Care, PA | Memphis | Tennessee | 38119 | — |
| Eye Clinics of South Texas | San Antonio | Texas | 78209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00894530, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 20, 2013 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00894530 live on ClinicalTrials.gov.